Last reviewed · How we verify
NCT07240987
Mesenchymal Stem Cells for Chronic Kidney Diseases
Phase 1, PHASE2 trial testing 0.9% sodium chloride in Kidney Disease, Chronic in 32 participants. Not yet recruiting.
31 August 2027
Quick facts
| Lead sponsor | The First Affiliated Hospital of Air Force Medicial University |
|---|---|
| Phase | Phase 1, PHASE2 |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 32 |
| Start date | 1 January 2026 |
| Primary completion | 31 August 2027 |
| Estimated completion | 31 August 2027 |
Drugs / interventions tested
- 0.9% sodium chloride
- MSCs — full drug profile →
Conditions studied
- Kidney Disease, Chronic — all drugs for Kidney Disease, Chronic →
- Diabetic Kidney Disease (DKD) — all drugs for Diabetic Kidney Disease (DKD) →
- Hypertensive Nephropathy — all drugs for Hypertensive Nephropathy →
Sponsor
The First Affiliated Hospital of Air Force Medicial University
Who can join
18 and older, any sex, with Kidney Disease, Chronic or Diabetic Kidney Disease (DKD). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will evaluate the effect of intravenous injection of umbilical cord tissue derived mesenchymal stem cells (UMSCs) on the improvement of renal function in patients with chronic kidney disease (CKD) at stage 3 or 4, with the change of estimated glomerular filtration rate (eGFR) as the primary endpoint, and other changes in renal function laboratory indicators, changes in other organ system function laboratory indicators, and adverse reaction events as secondary endpoints. This trial aims to further evaluate the efficacy and safety of UMCSs in CKD patients, and provide new insights into expanding the clinical treatment strategies, delaying the progression and improving the prognosis of CKD patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07240987
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of 0.9% sodium chloride
Trials testing the same drug.
- NCT06823180 — Hydromorphone Hydrochloride Epidural Preemptive Analgesia for Postoperative Pain After Cesarean Section · Phase 4 · completed
- NCT06086431 — Dexamethasone Vs. Dexmedetomidine for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery · Phase 4 · completed
- NCT06034366 — the Efficacy of 0.01% Atropine for Near Work-induced Transient Myopia and Myopic Progression · NA · unknown
- NCT05811676 — Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women With Placenta Previa · Phase 3 · completed
- NCT04410042 — Tranexamic Acid Use to Reduce Blood Transfusion in Pediatric Cancer Patients Undergoing Limb Salvage Procedure · Phase 3 · terminated
Other recruiting trials for Kidney Disease, Chronic
Currently open trials in the same condition.
- NCT07217535 — Rutgers University Study of the Genetics of Kidney Disease · recruiting
- NCT06343727 — A High Protein Egg White Pudding for People With Kidney Failure (HiPE KF) · NA · recruiting
- NCT06701825 — Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus · Phase 4 · recruiting
- NCT06830473 — KTRSensor Scotland Study: An Observational Study Into Predictors and Diagnosis of Kidney Transplant Rejection · recruiting
- NCT06863194 — Probiotic Supplementation and Disease Progression in CKD: A Randomized Trial · Phase 1, PHASE2 · recruiting
Other The First Affiliated Hospital of Air Force Medicial University trials
Trials by the same sponsor.
- NCT07266181 — Safety and Efficacy of CD19 Chimeric Antigen Receptor T-Cell (CAR-T) in the Treatment of Refractory Membranous Nephropat · Phase 1 · recruiting
- NCT07198659 — A Single-Arm Investigator-Initiated Tria (IIT) Evaluating the Safety and Preliminary Efficacy of Autologous Drug-Loaded · EARLY_PHASE1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07240987 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The First Affiliated Hospital of Air Force Medicial University
- Last refreshed: 24 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07240987.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing